학술논문
Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment.
Document Type
Article
Author
Source
Subject
*OSIMERTINIB
*LUNGS
*ADENOCARCINOMA
*THERAPEUTICS
*
*
*
Language
ISSN
2473-4284
Abstract
A challenging case of Rhabdomyoblastic Transformation of EGFR-mutant Lung Adenocarcinoma after treatment with Osimertinib and Savolitinib. [ABSTRACT FROM AUTHOR]